Back to search

Article

Immune and clinical features of CD96 expression in glioma by large-scale analysis

2020-02-14

Abstract excerpt

<title>Abstract</title> <p>Background: Immune checkpoints target regulatory pathways in T cells which enhance antitumor immune responses and elicit durable clinical responses . As a novel immune checkpoint, CD96 is an attractive key target for cancer immunotherapy. However, there is no integrative investigation of CD96 in glioma. Our study explored the relationship between CD96 expression and clinical prognosis i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c7e50c0a-cab2-56de-bf0e-e872db611fb1
DOI
10.21203/rs.2.23546/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immune and clinical features of CD96 expression in glioma by large-scale analysisDOI 10.21203/rs.2.23546/v1
Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosisSemantic proximity
Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse gliomaSemantic proximity
Novel interferon-gamma-related 2-gene signature predicts outcome and responsiveness to immune checkpoint blockade in gliomaSemantic proximity
Prognostic Gene Expression Signature in Patients With Distinct Glioma GradesSemantic proximity
Development of An Inflammatory Response-Related Gene Signature To Predict Prognosis and Immunotherapy Response For Patients With GliomaSemantic proximity
Molecular and clinical characterization of CD163 expression via large-scale analysis in gliomaSemantic proximity
FNDC3B is a Potential Prognostic Biomarker and Correlated With Immune Infiltrates in GliomaSemantic proximity
Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade gliomaSemantic proximity
Identification of Potential Immune Checkpoint Inhibitor Targets in Gliomas via Bioinformatic Analyses.Semantic proximity
Natural Killer Cell-Related Gene Signature Predicts Malignancy of Glioma and the Survival of PatientsSemantic proximity
Predictive Panel for Immunotherapy in Low-Grade Glioma.Semantic proximity
Development and Validation of a Novel Prognostic Model for Glioma Based on Immune-Related GenesSemantic proximity
Select a neighboring publication to make it the new centre.